Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,693,896
+$575,809 QoQ
Shares Held
153,401
+38.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#726
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. PFE ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
This page
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,693,896 | 153,401 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,118,087 | 111,043 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $716,323 | 28,768 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $654,020 | 25,668 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $640,372 | 26,418 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $691,300 | 27,281 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $721,111 | 27,181 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $800,017 | 27,644 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $794,464 | 28,394 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $787,933 | 28,394 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $788,673 | 27,394 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $908,658 | 27,394 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,004,811 | 27,394 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,199,887 | 29,409 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,506,917 | 29,409 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,286,937 | 29,409 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,468,459 | 28,008 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,539,329 | 29,734 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,804,508 | 30,559 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,288,536 | 29,959 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $1,148,719 | 29,334 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,062,770 | 29,334 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,044,815 | 28,384 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,232,531 | 33,584 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $888,427 | 27,169 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,402,636 | 42,973 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||